Countries Experiences on Access to Injection Equipment Sophie Logez WHO/BCT/DCT Phnom Penh, 24-26 October 2002.

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.
Could the WHO Model List of Essential Medicines do more for the Rational and Safe Use of Injections? Logez S, Hutin Y, Holloway K, Robin G, Hogerzeil H.
10/07/02 Waste Management Planning Process in St Louis - Sénégal P. Jaillard, AMP, CVP/PATH SIGN Meeting, Phnom Penh.
Promoting Rational Use of Injections within National Medicine Policies World Health Organisation Dept. Essential Drugs and Medicines Policy Safe Injection.
Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.
Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Essential medicines: the first generation Monday 30 May 2011, Chateau de Penthes, Geneva Margaretha Helling Borda (former Director WHO Action Programme.
Plan of Action to improve injection Safety Within the EPI.
The WHO injection safety assessment tool: first results SIGN Meeting 2001 New Delhi, India.
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
Prof. G. L. Monekosso WHO Regional Office for Africa.
1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.
Safe and Appropriate Use of Injection Activities of WHO’s Department of Blood Safety and Clinical Technology (BCT) Yvan Hutin Annual SIGN Meeting New Delhi.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Injection Safety Best Practices – Waste Management Richard M Carr.
Wilbert Bannenberg SARPAM
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
USING WHO INDICATORS TO MONITOR THE IMPLEMENTATION OF NATIONAL DRUG POLICY Relationship between country characteristic and background, structure, process.
Injection Safety IPV Global Workshop March 25, 2014.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Objective The aim was to investigate the impact of purchasing medicines jointly by the JPD for the four participating parties in the first tender on the.
Contraceptive Security and Health Sector Reform: Effects upon the Logistics Cycle Washington, D.C., October 25, 2007 REPUBLIC OF NICARAGUA MINISTRY OF.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
The Viral Hepatitis Prevention Board, 10 years of support to the control and prevention of viral hepatitis in Europe. Alex Vorsters Viral Hepatitis Prevention.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
Development of Injection Safety Assessment Toolbox Rebecca Fields The CHANGE Project/USAID.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
NORTH AMERICAN HEALTHCARE COMMITTEES. POLICY Facility shall have at least the following committees: Resident Care Infection Control Pharmaceutical Quality.
Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
Western Pacific Region 1 Bi-regional Malaria Surveillance and M&E Workshop, Phnom Penh, 6–7 May 2010 Bi-regional Workshop on Malaria Surveillance and Monitoring.
WHO support to countries in the area of medicines example of the African Region WHO/EDM Drug Action Programme.
FIFTH MEETING OF HEALTH TEAM IHP+ COUNTRIES 2 – 5 December 2014, Siem Reap, Cambodia SESSION 7c) Managing Purchasing and Stock in Guinea-Bissau Current.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
1 SADC POOLED PROCUREMENT STRATEGY FOR ESSENTIAL MEDICINES & HEALTH COMMODITIES AARTI PATEL: TA SADC PBP BOTSWANA NATIONAL TRIPS & IP WORKSHOP.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.
Estimating the Global Burden of HCV Infections Associated with Unsafe Health Care Injections Anja Hauri 1, Gregory Armstrong, 2 Yvan Hutin 1 1. WHO Headquarters,
Multi-country study on drug supply and distribution activities of faith-based supply organizations in sub-Saharan African countries, 2003 Sophie Logez.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
Regional Consultation Ensuring Safe Hospitals and Health Facilities in Disasters 8-10 December 2008 Cambodiana Hotel, Phnom Penh, Cambodiana.
Injection Safety in the Context of and. “The only thing standing in the way of saving millions of additional kids is ensuring an adequate supply of vaccines.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
UNICEF Autodisable Syringe Supply Prepared for SIGN / TECHNET Delhi, 27-30Aug 2001.
EDM Strategy for Working with Countries: the Uganda Example
Wilbert Bannenberg SARPAM
Procurement and Supply Management Policies
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Richard Laing EMP/WHO TBS 2012
Access framework HIV/AIDS, TB and Malaria
World Health Organization
Committee Task Statement (1)
Viral Hepatitis Prevention Board Secretariat
Essential Drugs and Medicines Policy (EDM) World Health Organization
Richard Laing WHO/PAU TBS 2013
Ensuring Injection Safety during Rubella Immunization Campaigns
Presentation transcript:

Countries Experiences on Access to Injection Equipment Sophie Logez WHO/BCT/DCT Phnom Penh, October 2002

Strategy for the Safe and Appropriate Use of Injections Behaviour change among patients and health-care workers Access to safe injection equipment and infection control supplies Appropriate management of sharps waste

Access to Injection Equipment Increased access to safe injection equipment improved injection practices:  1999, Immunization: WHO/UNICEF/UNFPA/ joint statement on the use of auto-disable syringes in immunization services  2002, Curative services: recommendations of the 12 th Expert Committee for the selection of essential medicines ACCESS

Countries experiences on access to injection equipment (1) Experiences in selected AFR and WPR countries –Burkina Faso –Guinea –Mongolia –Cambodia Interviews of the participants from 12 countries of the WPR national drug policy meeting, October 2002

Countries experiences in access to injection equipment (2) Burkina FasoMongoliaCambodiaGuinea Single-use equipment included in the national essential drug list Yes No Use of national drug procurement system for injection equipment YesNoYesNo Forecasting methodsConsumptionNoConsumptionNo Independent procurementYes NoN/A Joint distribution of essential drugs and injection equipment YesNoYesNo Local productionNoYesNo Sterilizable injection equipment usedNo Phased outYes Reported shortagesNoYes Unsterile injections-+/- ++

Situations in 12 Countries the WPRO Region ACCESS WPRO NDP participants survey Single-use equipment included in the national essential drug list 7/12 Use of national drug procurement system for injection equipment 11/ 12 Forecasting methodsConsumption: 11/12 Joint distribution of essential drugs and injection equipment 11/ 12 Local production 4/ 12

Conclusions A number of parameters will influence access to injection equipment and ultimately injection practices –inclusion in the essential drug list –use of the national drug procurement –joint distribution of medicines and injection equipment –local production Access and ultimately injection practices will depend upon the number of favourable parameters In WP region, some essential drug programmes may want to examine their procurement situation to: –identify unfavourable parameters –evaluate if shortages of equipment do not lead to unsafe practices

Draft WHO procurement guide for injection Equipment  Objective of the guide: Strengthen good quality purchase of injection equipment at affordable price (quality standards)  Audience: procurement officers, programme managers  Proposing practical tools: product selection, forecasting, method of procurement and selection of suppliers ACCESS